View Clinical Trial (Medical Research Study)
Alzheimer's Disease - Sherman Oaks CA (Clinical Trial 6735)
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.
|
 |
 |
| City: |
|
Sherman Oaks |
| State: |
|
CA |
| Zip Code: |
|
91403 |
| Study summary: |
|
For people with Alzheimer's there's no time to lose. Alzheimer's disease is a neurodegenerative disorder- a disorder in which the brain cells are lost. It is characterized by progressive loss of memory and cognitive function, such as movement control and decision-making ability. Alzheimer's disease is the most common cause of dementia in the elderly and affects about 18 million people worldwide- 5 million in the U.S. alone. Although there's currently no cure for Alzheimer's disease, research is under way to find a new investigational treatment aimed at slowing the progression of the disease. The current medications are mostly aimed at maximizing the remaining brain activity. That's why the ICARA study was created- to explore a new investigational treatment option.
If you are 50 to 88 years of age and have a diagnosis of probable Alzheimer's disease, you may be eligible to participate in the ICARA study.
Throughout the 83-week study, participants may receive the investigational drug, study-related physical exams and laboratory services at no charge. All participants will be monitored by a medical team, including a nurse or study coordinator and a physician.
Ask your doctor if the ICARA study is right for you.
|
|
|
|
| Clinic Profile: |
|
View Clinic Profile |
|
Clinical trials are medical research studies designed to test the safety and/or effectiveness of new drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at and participating in a study at About Clinical Trials or take the Participation Quiz to find out if you are a good candidate for clinical trial participation.